Customer speak
We value our strong relationship with Syngene to support C4 Therapeutics’ research efforts across chemistry and biology to advance targeted protein degradation science. The scientific discussions, flexibility, and transparency between the teams have been key to making our collaboration successful.

Chris Nasveschuk
Senior Vice President, Chemistry, C4 Therapeutics